Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols

Immunotherapy of cancer is now an essential pillar of treatment for patients with many individual tumor types. Novel immune targets and technical advances are driving a rapid exploration of new treatment strategies incorporating immune agents in cancer clinical practice. Immunotherapies perturb a co...

Full description

Saved in:
Bibliographic Details
Main Authors: Deborah Collyar, Christian M Capitini, Gary Kohanbash, Yana G Najjar, Carlo B Bifulco, Barbara Seliger, Holden T Maecker, Elizabeth Garrett-Mayer, Joe Yeong, Leslie Cope, Sacha Gnjatic, Sumit K Subudhi, Michael T Lotze, Saman Maleki Vareki, Alaa Ali, Laura Q M Chow, Tricia R Cottrell, Tullia C Bruno, Denise Goh, Codruta Chiuzan, Janis Taube, Ryan J Sullivan, Kristin G Anderson, Isabella C Glitza Oliva, Wim Vos, Paola Grandi, Susan Halabi, Julie Stein Deutsch, Ivan Diaz-Padilla, Anthony R Cillo, Genia Dubrovsky, Sarah Mullin, Elizabeth G Hill, Brian P Hobbs, Phyllis Pettit Nassi, Virgil H Simons, Chris H Takimoto
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/3/e010928.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/13/3/e010928.full

Similar Items